Amy Catherine Janes, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tobacco Use Disorder | 23 | 2024 | 703 | 6.500 |
Why?
|
Cues | 21 | 2024 | 874 | 5.290 |
Why?
|
Nicotine | 11 | 2024 | 678 | 2.750 |
Why?
|
Smoking | 21 | 2024 | 9055 | 2.500 |
Why?
|
Gyrus Cinguli | 10 | 2022 | 1114 | 2.060 |
Why?
|
Reward | 7 | 2020 | 968 | 1.970 |
Why?
|
Smoking Cessation | 8 | 2024 | 2056 | 1.460 |
Why?
|
Nerve Net | 8 | 2024 | 2288 | 1.420 |
Why?
|
Corpus Striatum | 7 | 2021 | 1234 | 1.380 |
Why?
|
Prefrontal Cortex | 7 | 2021 | 2219 | 1.300 |
Why?
|
Cerebral Cortex | 10 | 2021 | 5775 | 1.120 |
Why?
|
Magnetic Resonance Imaging | 42 | 2024 | 36415 | 1.120 |
Why?
|
Sex Characteristics | 5 | 2021 | 2640 | 0.990 |
Why?
|
Nucleus Accumbens | 4 | 2020 | 365 | 0.970 |
Why?
|
Neural Pathways | 9 | 2024 | 3056 | 0.870 |
Why?
|
Caudate Nucleus | 3 | 2020 | 390 | 0.840 |
Why?
|
Psychological Tests | 2 | 2024 | 639 | 0.830 |
Why?
|
Attention | 5 | 2018 | 2394 | 0.740 |
Why?
|
Brain | 21 | 2024 | 27092 | 0.730 |
Why?
|
Alcoholism | 3 | 2022 | 1973 | 0.730 |
Why?
|
Executive Function | 3 | 2018 | 1388 | 0.670 |
Why?
|
Nicotinic Agonists | 3 | 2018 | 265 | 0.670 |
Why?
|
Brain Mapping | 14 | 2024 | 6635 | 0.630 |
Why?
|
Hydrocortisone | 2 | 2023 | 1818 | 0.520 |
Why?
|
Self Report | 2 | 2024 | 3727 | 0.460 |
Why?
|
Cocaine-Related Disorders | 1 | 2017 | 460 | 0.460 |
Why?
|
Glutamic Acid | 3 | 2016 | 1173 | 0.440 |
Why?
|
Dopamine | 1 | 2020 | 1601 | 0.410 |
Why?
|
Substance-Related Disorders | 3 | 2024 | 4413 | 0.400 |
Why?
|
Emotions | 4 | 2024 | 2742 | 0.390 |
Why?
|
Facial Expression | 1 | 2015 | 507 | 0.390 |
Why?
|
Cocaine | 3 | 2017 | 958 | 0.380 |
Why?
|
Memory, Short-Term | 2 | 2018 | 982 | 0.380 |
Why?
|
Dopamine Uptake Inhibitors | 2 | 2009 | 297 | 0.360 |
Why?
|
Adult | 36 | 2024 | 221119 | 0.360 |
Why?
|
Limbic System | 1 | 2012 | 419 | 0.330 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2009 | 41 | 0.330 |
Why?
|
Young Adult | 17 | 2024 | 59221 | 0.330 |
Why?
|
Female | 45 | 2024 | 392544 | 0.320 |
Why?
|
Depressive Disorder, Major | 2 | 2018 | 4767 | 0.310 |
Why?
|
Receptors, Nicotinic | 1 | 2011 | 494 | 0.300 |
Why?
|
Male | 42 | 2024 | 360693 | 0.300 |
Why?
|
Reaction Time | 4 | 2022 | 2087 | 0.290 |
Why?
|
Stroop Test | 2 | 2022 | 71 | 0.290 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 614 | 0.270 |
Why?
|
Cross-Over Studies | 4 | 2021 | 2082 | 0.270 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2013 | 1139 | 0.270 |
Why?
|
Humans | 54 | 2024 | 761208 | 0.260 |
Why?
|
Cognition | 2 | 2020 | 6988 | 0.250 |
Why?
|
Recurrence | 5 | 2023 | 8457 | 0.240 |
Why?
|
Photic Stimulation | 3 | 2015 | 1984 | 0.210 |
Why?
|
Psychotic Disorders | 1 | 2018 | 3220 | 0.210 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2017 | 3707 | 0.210 |
Why?
|
Schizophrenia | 2 | 2018 | 6930 | 0.200 |
Why?
|
Image Processing, Computer-Assisted | 8 | 2024 | 8998 | 0.190 |
Why?
|
Motivation | 3 | 2021 | 2002 | 0.180 |
Why?
|
Databases, Factual | 1 | 2015 | 7966 | 0.170 |
Why?
|
Nerve Tissue Proteins | 2 | 2013 | 4404 | 0.170 |
Why?
|
Principal Component Analysis | 2 | 2012 | 942 | 0.150 |
Why?
|
Middle Aged | 17 | 2024 | 220853 | 0.150 |
Why?
|
Anticipation, Psychological | 1 | 2018 | 84 | 0.150 |
Why?
|
Choice Behavior | 1 | 2023 | 825 | 0.140 |
Why?
|
Double-Blind Method | 4 | 2018 | 12341 | 0.140 |
Why?
|
Behavior, Addictive | 2 | 2021 | 462 | 0.130 |
Why?
|
Artifacts | 1 | 2024 | 1912 | 0.130 |
Why?
|
Checklist | 1 | 2022 | 828 | 0.120 |
Why?
|
Discriminant Analysis | 1 | 2015 | 224 | 0.120 |
Why?
|
Menstrual Cycle | 1 | 2018 | 539 | 0.120 |
Why?
|
Memory | 3 | 2016 | 2190 | 0.120 |
Why?
|
Costs and Cost Analysis | 1 | 2020 | 1664 | 0.110 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2016 | 3770 | 0.110 |
Why?
|
Organ Size | 2 | 2019 | 2253 | 0.110 |
Why?
|
Pyrrolidines | 2 | 2013 | 339 | 0.110 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2017 | 624 | 0.100 |
Why?
|
Anabolic Agents | 1 | 2015 | 256 | 0.100 |
Why?
|
Dog Diseases | 1 | 2013 | 141 | 0.100 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2015 | 6011 | 0.100 |
Why?
|
Adolescent | 9 | 2024 | 88298 | 0.100 |
Why?
|
Health Behavior | 1 | 2023 | 2641 | 0.100 |
Why?
|
Saimiri | 1 | 2012 | 333 | 0.090 |
Why?
|
Cognition Disorders | 2 | 2016 | 3976 | 0.090 |
Why?
|
Gene Expression Regulation | 1 | 2009 | 11856 | 0.090 |
Why?
|
Parkinson Disease | 2 | 2016 | 2867 | 0.090 |
Why?
|
Macaca fascicularis | 1 | 2013 | 901 | 0.090 |
Why?
|
Oxygen | 2 | 2015 | 4227 | 0.090 |
Why?
|
Rats, Inbred WKY | 1 | 2010 | 150 | 0.090 |
Why?
|
Rats, Inbred SHR | 1 | 2010 | 186 | 0.090 |
Why?
|
Anxiety Disorders | 1 | 2021 | 2723 | 0.090 |
Why?
|
Rolipram | 1 | 2009 | 24 | 0.080 |
Why?
|
Computer Simulation | 1 | 2023 | 6224 | 0.080 |
Why?
|
Internal-External Control | 1 | 2010 | 358 | 0.080 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2009 | 213 | 0.080 |
Why?
|
Glycine | 1 | 2011 | 659 | 0.080 |
Why?
|
Androgens | 1 | 2015 | 1283 | 0.070 |
Why?
|
Functional Laterality | 1 | 2014 | 2257 | 0.070 |
Why?
|
Case-Control Studies | 5 | 2017 | 22174 | 0.070 |
Why?
|
Pilot Projects | 2 | 2017 | 8642 | 0.070 |
Why?
|
Rest | 1 | 2012 | 920 | 0.070 |
Why?
|
Parietal Lobe | 1 | 2012 | 852 | 0.070 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 894 | 0.070 |
Why?
|
Quinolines | 1 | 2011 | 764 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 26071 | 0.060 |
Why?
|
Pheromones | 1 | 2006 | 93 | 0.060 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2012 | 1990 | 0.060 |
Why?
|
Cell Count | 1 | 2009 | 1831 | 0.060 |
Why?
|
Behavior, Animal | 2 | 2012 | 1873 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2020 | 2164 | 0.060 |
Why?
|
Neuropsychological Tests | 3 | 2016 | 7046 | 0.060 |
Why?
|
Neurons | 3 | 2019 | 9428 | 0.060 |
Why?
|
Olfactory Bulb | 1 | 2006 | 197 | 0.060 |
Why?
|
Motor Activity | 2 | 2017 | 2712 | 0.060 |
Why?
|
Psychomotor Performance | 1 | 2013 | 1880 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2009 | 6223 | 0.060 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2013 | 1492 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2024 | 64681 | 0.060 |
Why?
|
8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2003 | 32 | 0.060 |
Why?
|
Time Factors | 3 | 2017 | 39957 | 0.060 |
Why?
|
Lysergic Acid Diethylamide | 1 | 2003 | 47 | 0.050 |
Why?
|
Amygdala | 2 | 2015 | 1353 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2006 | 582 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18384 | 0.050 |
Why?
|
Temporal Lobe | 1 | 2010 | 1695 | 0.050 |
Why?
|
Serotonin Receptor Agonists | 1 | 2003 | 151 | 0.050 |
Why?
|
Regression Analysis | 1 | 2012 | 6345 | 0.050 |
Why?
|
Frontal Lobe | 1 | 2009 | 1416 | 0.050 |
Why?
|
Receptors, Serotonin | 1 | 2003 | 208 | 0.050 |
Why?
|
Hypertrophy | 2 | 2015 | 558 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 4851 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2024 | 20119 | 0.040 |
Why?
|
Conditioning, Classical | 1 | 2003 | 367 | 0.040 |
Why?
|
Alleles | 1 | 2011 | 6857 | 0.040 |
Why?
|
Brain Chemistry | 1 | 2003 | 959 | 0.040 |
Why?
|
Behavior | 1 | 2021 | 540 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39126 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 848 | 0.040 |
Why?
|
Pregnancy | 1 | 2020 | 29893 | 0.040 |
Why?
|
Animals | 10 | 2022 | 168079 | 0.040 |
Why?
|
Analgesics, Opioid | 1 | 2013 | 3805 | 0.030 |
Why?
|
Aging | 1 | 2016 | 8702 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15841 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2022 | 834 | 0.030 |
Why?
|
Feces | 1 | 2022 | 1490 | 0.030 |
Why?
|
Psychomotor Disorders | 1 | 2016 | 149 | 0.030 |
Why?
|
Suicide, Attempted | 1 | 2024 | 1402 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2013 | 18220 | 0.030 |
Why?
|
Inositol | 1 | 2015 | 215 | 0.030 |
Why?
|
Cerebrovascular Circulation | 1 | 2024 | 2725 | 0.030 |
Why?
|
Verbal Learning | 1 | 2016 | 463 | 0.030 |
Why?
|
Benzeneacetamides | 1 | 2013 | 36 | 0.030 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2013 | 98 | 0.030 |
Why?
|
Laboratory Animal Science | 1 | 2012 | 9 | 0.030 |
Why?
|
Receptors, Opioid, mu | 1 | 2013 | 167 | 0.020 |
Why?
|
Receptors, Opioid, kappa | 1 | 2013 | 138 | 0.020 |
Why?
|
Glutamine | 1 | 2015 | 574 | 0.020 |
Why?
|
Hemodynamics | 1 | 2022 | 4165 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 15920 | 0.020 |
Why?
|
Restraint, Physical | 1 | 2013 | 185 | 0.020 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2013 | 617 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2013 | 1376 | 0.020 |
Why?
|
Mice | 3 | 2022 | 81326 | 0.020 |
Why?
|
Fentanyl | 1 | 2013 | 433 | 0.020 |
Why?
|
Hypertension | 1 | 2010 | 8536 | 0.020 |
Why?
|
Anisotropy | 1 | 2013 | 1284 | 0.020 |
Why?
|
Creatine | 1 | 2011 | 427 | 0.020 |
Why?
|
Administration, Cutaneous | 1 | 2011 | 713 | 0.020 |
Why?
|
Dogs | 1 | 2013 | 3832 | 0.020 |
Why?
|
Self Administration | 1 | 2009 | 387 | 0.020 |
Why?
|
Computational Biology | 1 | 2019 | 3499 | 0.020 |
Why?
|
Consensus | 1 | 2017 | 3134 | 0.020 |
Why?
|
Rats | 3 | 2010 | 23704 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10516 | 0.020 |
Why?
|
Wakefulness | 1 | 2013 | 1264 | 0.020 |
Why?
|
Castration | 1 | 2006 | 150 | 0.020 |
Why?
|
Lidocaine | 1 | 2009 | 538 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2013 | 1405 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2011 | 1472 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2009 | 1848 | 0.020 |
Why?
|
Indicators and Reagents | 1 | 2006 | 453 | 0.020 |
Why?
|
Aged | 4 | 2020 | 169288 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10218 | 0.010 |
Why?
|
Urine | 1 | 2006 | 362 | 0.010 |
Why?
|
Zimeldine | 1 | 2003 | 2 | 0.010 |
Why?
|
Receptors, Serotonin, 5-HT1 | 1 | 2003 | 13 | 0.010 |
Why?
|
Catheterization | 1 | 2009 | 1428 | 0.010 |
Why?
|
Cholera Toxin | 1 | 2006 | 559 | 0.010 |
Why?
|
Receptor, Serotonin, 5-HT2A | 1 | 2003 | 64 | 0.010 |
Why?
|
Buspirone | 1 | 2003 | 80 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13511 | 0.010 |
Why?
|
Rats, Long-Evans | 1 | 2003 | 380 | 0.010 |
Why?
|
Corticosterone | 1 | 2003 | 301 | 0.010 |
Why?
|
Autoradiography | 1 | 2003 | 729 | 0.010 |
Why?
|
Central Nervous System Depressants | 1 | 2003 | 164 | 0.010 |
Why?
|
Anesthetics, Local | 1 | 2009 | 998 | 0.010 |
Why?
|
Cohort Studies | 1 | 2024 | 41496 | 0.010 |
Why?
|
Learning | 1 | 2010 | 1737 | 0.010 |
Why?
|
Anti-Anxiety Agents | 1 | 2003 | 397 | 0.010 |
Why?
|
Iodine Radioisotopes | 1 | 2003 | 1030 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2013 | 4487 | 0.010 |
Why?
|
Ethanol | 1 | 2003 | 1322 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10756 | 0.010 |
Why?
|
Child | 1 | 2024 | 80152 | 0.010 |
Why?
|
Piperidines | 1 | 2003 | 1656 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11067 | 0.010 |
Why?
|